| Date | Title | Description |
| 24.10.2024 | Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers | Designed to make next-generation sequencing accessible to more labs
With room-temperature kit storage and shipping, Illumina's newest sequencers remove barriers to enable more insights and discoveries
SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -... |
| 23.10.2024 | Corvex founder Meister sees big upside for stocks already targeted by others | Sustainable Finance & ReportingShareholder Activism
Corporate Structure
Corvex founder Meister sees big upside for stocks already targeted by others
By Svea Herbst-BaylissOctober 22, 20249:33 PM UTCUpdated ago
Text
Small Text
Medium Tex... |
| 19.10.2024 | MEDiC Life Sciences: Pioneering Cancer Solutions with $5 Million Boost | In the heart of Silicon Valley, a new force is emerging in the battle against cancer. MEDiC Life Sciences, a functional genomics startup, has secured a strategic investment of $5 million from LG and Hanmi Pharmaceutical. This funding marks ... |
| 18.10.2024 | MEDiC Life Sciences: Functional Genomics Company Raises $5 Million | MEDiC Life Sciences, a leading functional genomics startup in Silicon Valley, announced a $5 million strategic investment from LG and Hanmi Pharmaceutical. This funding comes ahead of MEDiC’s planned Series-A round later this year. Previous... |
| 15.10.2024 | MEDiC Life Sciences Raises $5M in Strategic Funding | MEDiC Life Sciences, a Mountain View, CA-based functional genomics startup, raised $5M in strategic funding.
The round was led by LG and Hanmi Pharmaceutical.
The company intends to use the funds to accelerate the adoption of its cancer bio... |
| 19.09.2024 | Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture | Amid rising agricultural complexity and the push for sustainability, genomics is at the forefront of innovation in breeding practices.
SINGAPORE, Sept. 19, 2024 /PRNewswire/ -- Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Bi... |
| 19.09.2024 | 3 Genomics Stocks Transforming Healthcare Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investin... | Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investing in fundamentally sound genomics stocks like Regeneron Pharmaceuticals (REGN), Al... |
| 13.09.2024 | These Female Founders And CEOs Raised The Biggest Rounds In 2024 | 6 Shares Email Facebook Twitter LinkedIn
When measuring funding to startups with female founders and CEOs, the perennial takeaway is that women remain underrepresented. Last year, for instance, just 3% of U.S. funding went to startups with ... |
| 07.09.2024 | CytoTronics Secures $13.5 Million to Revolutionize Cell Biology | In the bustling world of biotechnology, CytoTronics has emerged as a beacon of innovation. The Boston-based company recently announced a significant milestone: a $13.5 million Series Seed 2 funding round. This infusion of capital is not jus... |
| 07.09.2024 | CytoTronics: Cell Biology Discovery Tech Company Raises $13.5 Million (Seed Extension) | CytoTronics, a pioneer of semiconductor-based platforms for discovery in cell biology, announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors.
New investor LYFE C... |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share
Tweet
Share
Share
Email
In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 21.08.2024 | Enhancing NGS Sample Preparation from Sample to the Sequencer, Upcoming Webinar Hosted by Xtalks | www.benchling.com
In this free webinar, learn about sample preparation can be elevated with next-gen sequencing (NGS) supported solutions. Attendees will discover how direct data ingestion from bioanalyzers and plate readers increases the t... |
| 12.08.2024 | The Surge of Healthcare Innovation: A Look at Recent Developments in Southeast Asia | In the bustling landscape of Southeast Asia, healthcare innovation is taking center stage. Recent developments highlight a surge in demand for advanced medical solutions and the rise of startups that are reshaping the industry. This article... |
| 12.08.2024 | Truva, 4baseCare, two others secure early-stage funds | 4baseCare founders Hitesh Goswami (Left) and Kshitij Rishi
Oncology solutions startup 4baseCare, wealth management platform Infinyte.Club, real estate technology startup Truva, healthcare financing startup HealthCRED and Mumbai-based luxury... |
| 29.07.2024 | Predicta Biosciences: Pioneering a New Era in Cancer Diagnostics | Predicta Biosciences is making waves in the ocean of cancer diagnostics. With a fresh infusion of $5.2 million in seed funding, this Boston-based precision oncology company is poised to change the landscape of how we detect and treat blood ... |
| 27.07.2024 | Predicta Biosciences Raises $5.2 Million To Develop Novel Diagnostic And Therapeutic Products | Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, announced it had raised an oversubscribed $5.2 million seed round led by The Engine Ventures. And additional participating investors in... |
| 03.07.2024 | Apple set to get OpenAI board observer role | Apple Fellow Phil Schiller
Apple will get an observer role on OpenAI’s board as part of a landmark agreement announced last month, further tightening ties between the once-unlikely partners.
Phil Schiller, the head of Apple’s App Store and ... |
| 07.06.2024 | KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 | NEW YORK, June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Mo... |
| 05.06.2024 | Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost | SAN DIEGO - PRNewswire -- Illumina Inc., a global leader in DNA sequencing and array-based technologies, announces it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 ne... |
| 04.06.2024 | Illumina approves Grail spinoff plan | figcaption>span]:font-sans">
Illumina on Tuesday said its board has approved plans to spin off Grail, the early cancer screening company it founded, spun off, and then reacquired for $8 billion over the objections of antitrust re... |
| 03.06.2024 | Unlocking precision medicine: An overview of Illumina's TSO500, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, learn about comprehensive genomic profiling (CGP) and the application of next-generation sequencing in oncology clinical trial biomarker studies. Attendees will gain insights into TruSight Oncology 500 ... |
| 01.06.2024 | Xtalks Announces its Life Science Webinar Calendar for June 2024 | www.xtalks.com
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, food, healthcare, laboratory technolog... |
| 16.05.2024 | Bolstering Strategic Growth, Swinerton Hires National Director of Life Sciences | Marcella Ayala, Swinerton National Director of Life Sciences
J. Marcella Ayala brings her extensive knowledge and passion to lead Swinerton's growth in the Life Sciences construction.
LOS ANGELES, May 15, 2024 /PRNewswire/ -- Swinerton, an ... |
| 15.05.2024 | Chinese biotech crackdown would reset U.S. drug development | figcaption>span]:font-sans">
Lawmakers in the House of Representatives on Wednesday are expected to set in motion a massive reordering of how U.S. pharmaceuticals are developed and made, by advancing a contracting ban on five key... |
| 13.05.2024 | Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK | BURLINGTON, Mass., May 13, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further i... |
| 29.04.2024 | Chromosome polymorphism a key factor in recurrent pregnancy loss: Study | - |
| 26.04.2024 | Exagen Inc. Announces Changes to the Board of Directors | CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors.
Exagen is pleased to announce Scott Kahn, Ph.D. is joining... |
| 25.04.2024 | Business | FTC chief says tech advancements risk health care price fixing | Julie Rovner, David Hilzenrath | (TNS) KFF Health News
New technologies are making it easier for companies to fix prices and discriminate against individual consumers, the Biden administration’s top consumer watchdog said Tuesday.
Algorithm... |
| 23.04.2024 | Genomics Luminary and former Illumina Executive Bob Kain Joins Single Technologies as an Advisor | Genomics Luminary and former Illumina Executive Bob Kain Joins Single Technologies as an Advisor
Tue, Apr 23, 2024 09:00 CET Report this content
Stockholm, Sweden, 23 April 2024 – Renowned genomics pioneer, Bob Kain, has joined Single Techn... |
| 13.03.2024 | Global Genomics Research Report 2024: A $70.5+ Billion Industry by 2031 - Analysis by Sequencing, Microarray, PCR, Nucleic Acid Extraction, Drug Discovery, Diagnostic, and Research | - |
| 11.03.2024 | Life Science Tools Market Expected to Expand at a Steady 2024-2031 | Illumina, Inc., Thermo Fisher Scientific Inc | Life Science Tools Market
life science tools market is estimated to be valued at US$ 111.28 billion in 2022 and is expected to exhibit a CAGR of 12.5% during the forecast period BURLINGAME, CALIFORNIA , UNITED STATES, March 11, 2024 /EINPre... |
| 11.03.2024 | In Vitro Diagnostics (IVD) Market is Expected to Reach $130.1 Billion by 2030 - Exclusive Report by Meticulous Research® | According to Meticulous Research®, the global in vitro diagnostics market is expected to register a CAGR of 4.6% from 2023 to reach $130.1 billion by 2030. REDDING, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- According to a new mark... |
| 08.03.2024 | Asia-Pacific Organ Transplant Diagnostics Market Forecast to Reach $3.45 Billion by 2033 - Advancements in Human Leukocyte Antigen (HLA) Typing Tests Present Opportunities | - |
| 07.03.2024 | Next Generation Sequencing Market Research 2024: Global Industry Trends, Share, Growth, Insight, Opportunity Company Analysis 2023-2030 | - |
| 06.03.2024 | Sequencing Consumables Market to Grow at CAGR of 23.76% through 2033; Increased Funding for Genomic Research to Propel Growth | - |
| 05.03.2024 | Global Genetic Testing Market Outlook 2024-2030: A $37+ Billion Opportunity with Abbott Labs, Danaher Corp (Cepheid), and Illumina Leading the Competition | - |
| 04.03.2024 | Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024 | Researchers present abstracts and poster sessions showcasing research and clinical solutions
Joint session planned with Illumina
HOUSTON, March 04, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront ... |
| 19.12.2023 |
Illumina will divest Grail after court backs FTC ruling | Illumina (Nasdaq:ILMN) announced that it plans to divest Grail after a drawn-out legal battle over the $7.1 billion acquisition.
In September 2020, Illumina announced an agreement to acquire Grail, a DNA sequencing and array-based tech deve... |
| 12.12.2023 | Illumina partners with HaploX to build a domestically produced flagship benchtop sequencing system | SHENZHEN, China, Dec. 12, 2023 /PRNewswire/ -- On December 9, Illumina, a global leader in DNA sequencing and array-based technologies, and HaploX, a China-based high-tech company specializing in oncology liquid biopsy and genetic big data,... |
| 13.11.2023 | Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries | Program aims to address key barriers to genomic sequencing in-country
SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the G... |
| 10.11.2023 | The first vaccine for the increasingly prevalent chikungunya virus is here | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today we have two FDA approvals, preview late-breakers at this weekend’s American Heart Association scientific sessi... |
| 12.06.2023 |
Illumina’s CEO resigns, MacMillan expresses confidence | Illumina Inc. (NASDAQ: ILMN) announced that CEO Francis deSouza has resigned from the DNA sequencing and array-based tech developer.
The news, announced yesterday, comes more than a week after Hologic CEO Stephen MacMillan became non-execut... |
| 02.06.2023 | Illumina Unveils AI Software to Predict Disease-Causing Genetic Mutations in Patients | Illumina a global leader in DNA sequencing and array-based technologies,announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented accuracy disease-causing genetic mutations in patients. The r... |
| 02.06.2023 |
Hologic CEO MacMillan to chair Illumina’s board | Hologic CEO Stephen MacMillan
Illumina (NASDAQ: ILMN) announced today that its board has elected Hologic CEO Stephan MacMillan to fill a new seat and become its non-executive chair.
Edwards Lifesciences CFO Scott Ullem will fill a second ne... |
| 10.05.2023 | Библиотека в пробирке: новый метод кодирования данных на ДНК | В контексте возраста планеты Земля человечество как вид существует не так давно. Однако за это время мы успели пройти невероятный эволюционный путь, в ходе которого нам открывались все новые и новые знания. С открытием письменности мы получ... |
| 25.04.2023 | Managers, Hybrid Is Here: Shift Your Approach To Make It Work | Dr. Lisa Toppin, Global Head of Diversity, Equity and Inclusion Illumina Inc. |
| 13.04.2023 | Illumina’s Cloud-based Informatics Programs Recognized For Robust, International Data Privacy Protections | Illumina, a global leader in DNA sequencing and array-based technologies, announced it has received the international privacy certification of six of its cloud-based informatics programs. The certification, ISO/IEC 27701, recognizes that Il... |
| 10.04.2023 | Eighteen Leaders Recognized As 2023 SEAL Sustainability Leader Award Winners | Sustainability professionals face a difficult task of driving meaningful impact despite having limited resources and headcount, the strong nominations our 2023 award recipients received reflect the high standard of excellence in ESG leaders... |
| 07.04.2023 | The Old CEO’s Back, but It Doesn’t Mean Things Will Get Better | Activist investor Carl Icahn is pushing to get directors added to the board of life-sciences firm Illumina but he’s not stopping there.
He also wants to oust Illumina (ticker: ILMN) CEO Francis deSouza, and replace him with his predecessor,... |
| 24.03.2023 | World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa | Transformative Next Generation Sequencing (NGS) Innovation expands access to genomic testing and enables personalized medicine for patients with Tuberculosis (TB)
CAPE TOWN, South Africa, March 24, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ... |
| 24.03.2023 | Illumina Issues Statement in Response to Carl Icahn's Letter | SAN DIEGO, March 24, 2023 /PRNewswire/ -- Illumina, Inc. ILMN, a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, 2023:
Directors and Office... |
| 15.03.2023 | Illumina launches its first product enabling long- and short-read sequencing on one instrument | Early customer data reinforces accuracy and flexibility of novel long-read technology, unlocking access to challenging, low DNA input samples
SAN DIEGO, March 15, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA seq... |
| 14.12.2022 | Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP | As of December 9, 2022 Illumina awarded highest score from S&P Dow Jones Indices in Life Sciences Tools & Services Sector
Illumina received leadership score with an A- from CDP
SAN DIEGO, CA / ACCESSWIRE / December 14, 2022 / Illumi... |
| 22.11.2022 | TATAA Biocenter goes live with a modern, fully-automated LIMS – a big day for their state-of-the-art laboratory in Gothenburg. | TATAA Biocenter goes live with a modern, fully-automated LIMS – a big day for their state-of-the-art laboratory in Gothenburg.
Tue, Nov 22, 2022 11:30 CET Report this content
It’s been over 12 months in the making and TATAA Biocenter has no... |
| 19.09.2022 | Exclusive: Indonesian biotech startup gets funding from global accelerator | Premium Content
It takes our newsroom weeks - if not months - to investigate and produce stories for our premium content. You can’t find them anywhere else.
Gabriel Budi Sutrisno · 2d ago · 2 min readExclusive: Indonesian biotech startup ge... |
| 01.09.2022 | Illumina wins case against FTC in bid to hold onto early cancer detection company Grail | SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired for $8 billion last year.
An ad... |
| 29.08.2022 | Minderoo Foundation and Illumina Commit $40M to Apply Advanced Genomics to Marine Conservation | New partnership will use the power of high-throughput sequencing to measure and understand marine life in our oceans at a rate that eclipses traditional research methods
SAN DIEGO, Aug. 29, 2022 /PRNewswire/ -- Minderoo Foundation and Illum... |
| 19.08.2022 | Minderoo Foundation and Illumina Commit $40M to Apply Advanced Genomics to Marine Conservation | New partnership will use the power of high-throughput sequencing to measure and understand marine life in our oceans at a rate that eclipses traditional research methods
SAN DIEGO, Aug. 19, 2022 /PRNewswire/ -- Minderoo Foundation and Illum... |
| 29.07.2022 | Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target | The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050
SINGAPORE, July 29, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-bas... |
| 19.07.2022 | llumina Among First in the World to Receive Approval of Science-Based Net-Zero Target | The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050
SINGAPORE, July 19, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-bas... |
| 29.06.2022 | A Week At The Most Secretive Conference On Aging | Gordon Research Conference (GRC) Systems Aging 2022. Row 1: Vera Gorbunova, Cavin Ward-Caviness, ... [+] Samuel Beck, Sruthi Sivakumar, Vittorio Sebastiano, Steve Horvath, Vadim Gladyshev, Morgan Levine, Daniel Promislow, Brianah McCoy, Ric... |
| 10.06.2022 | Illumina Loses Its CFO. Why the Stock Doesn’t Need Any More Surprises. | Shares of Illumina were falling sharply Friday after the gene-sequencing supplier said that Sam Samad would be departing as its chief financial officer.
Samad will leave Illumina (ticker: ILMN) on July 8, after serving as CFO for more than ... |
| 16.05.2022 | Illumina, Deerfield Ink Drug Development Deal | Illumina, Inc. is expanding its reach into drug discovery and development.
On May 5, the San Diego DNA sequencing giant announced a partnership with New York-based healthcare investment management firm Deerfield Management to apply a geneti... |
| 06.05.2022 |
Illumina Links With Investor Deerfield Management
| San Diego-based life sciences equipment maker Illumina and healthcare investor Deerfield Management said Thursday that the two companies are in a five-year partnership on "discovery and development of novel therapies for diseases with ... |
| 17.02.2022 | 15 Topics That Add Value To (Basic) Employee Training Programs | Your employee training program documents may look good on paper, but is it actually benefiting your current employees or new hires who want to succeed at what they do and giving them the opportunity to grow in real-time? |
| 11.02.2022 | Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021 | SAN DIEGO, Feb. 10, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2021, which include the consolidated financial results of GRAIL.
Fourth quarter consolidated... |
| 03.02.2022 | Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer | SAN DIEGO, Feb. 3, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to assess the clinical value of comprehensive genomic profi... |
| 11.01.2022 | Illumina delivers 2021 results ahead of expectations | Illumina delivers 2021 results ahead of expectations
11-01-2022
Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS che... |
| 11.01.2022 | Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference | SAN DIEGO, Jan. 10, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed today the company's strong growth trajectory, including 2021 results and 2022 guidance. deSouza also announced new par... |
| 05.01.2022 | Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices | What You Should Know:
– Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community onc... |
| 18.11.2021 | Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in China | SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), and Sequoia Capital China, a leading investment firm, today jointly announced the selection of the first two startup companies joining the Sequoia Capital China Intelli... |
| 15.11.2021 | $5M Boost to Innovation in Australia with New Illumina Genomics Lab | New laboratory opens in Melbourne Biomedical Precinct to accelerate the adoption of genomics in healthcare and agriculture in Australia.
MELBOURNE, Australia, Nov. 15, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), the global leader in... |
| 04.11.2021 | Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021 | SAN DIEGO, Nov. 4, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2021, which include the consolidated financial results of GRAIL.
Third quarter consolidated res... |
| 30.09.2021 | Illumina : Expands Presence in Latin America | SAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced the creation of Illumina Colombia S.A.S. and Illumina México Productos de Biotecnología marking our commitment to expand genomics in Latin America and increas... |
| 20.09.2021 | Illumina reaffirms commitment to the National Project of Bio Big Data in Korea | MELBOURNE, Australia, Sept. 20, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that the National Project of Bio Big Data in Korea has selected Illumina technology for the second pilot project in their effort to work towa... |
| 20.09.2021 | Time for round 2: Illumina-backed VC snags $325M for its next fund | Illumina Ventures closed off its second investment fund with a total commitment of $325 million, offering fresh fuel to back a slate of startups that have already included a smorgasbord of companies, covering everyt... |
| 16.09.2021 | FDA accepts Intellia's IND for CRISPR and TCR-T cell therapy; Santé closes Fund IV at $260M | Riding the coattails of a massive $600 million cash raise in June, Intellia announced that the FDA accepted their IND application for their gene editing treatment NTLA-5001, built as a treatment for acute myeloid leukemia.
T... |
| 16.09.2021 |
Illumina Accelerator Backs Seven Startups
| San Diego-based life sciences giant Illumina says it has made investments in seven startups, as part of its accelerator program, the Illumina Accelerator. The company said that the investments were made as part of two different programs, th... |
| 16.09.2021 | 54gene secures $25m funding to advance drug discovery in Africa | 54gene, a Nigerian health tech company advancing African genomics research for improved global health outcomes, has secured $25M in a Series B round.
The round was led by Cathay AfricInvest Innovation Fund with participation from Adjuvant C... |
| 16.09.2021 | African genomics startup 54gene raises $25M to expand precision medicine capabilities | Less than 3% of genetic material used in global pharmaceutical research is from Africa. The staggering gap is quite surprising because Africans and people of African descent are reported to be more genetically diverse than any other populat... |
| 16.09.2021 | Illumina Accelerator invests in seven genomics startups for third global cycle | Illumina Accelerator invests in seven genomics startups for third global cycle
16-09-2021
llumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global comp... |
| 15.09.2021 | Illumina : Accelerator Invests in Seven Genomics Startups for Third Global Cycle | SAN DIEGO, Sept. 15, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company creation engine, focused on partnering with... |
| 07.09.2021 | Myriad Genetics : Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations | SAN DIEGO, Sept. 7, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in th... |
| 07.09.2021 | Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations | |
| 19.08.2021 | Ally Bridge Portfolio News – Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test | GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review
SAN DIEGO, Aug. 18, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused o... |
| 18.08.2021 | Illumina : Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test | SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company du... |
| 18.08.2021 | Illumina Moves Forward with Acquisition of GRAIL | Illumina, Inc. headquarters in San Diego, Calif. Illumina (NASDAQ: ILMN) announced that it will acquire GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, despite an ongoing regulatory review by the Euro... |
| 18.08.2021 | Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test | |
| 15.08.2021 | Illumina Sees Record Growth | Photo courtesy of Illumina. UTC-based Illumina is on track to a $4 billion year following strong second quarter results. Illumina, a leader in DNA sequencing and array-based technologies, posted a record $1.13 billion in revenue during its ... |
| 05.08.2021 | Illumina : Reports Financial Results for Second Quarter of Fiscal Year 2021 | SAN DIEGO, Aug. 5, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2021.
Second quarter results reflect record revenue:
Revenue of $1,126 million, a 78% increase... |
| 05.08.2021 | Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021 | |
| 12.04.2021 | AWS launches next phase of COVID-19 diagnostic tools with $20M, expanded scope
Since you’re here …
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Amazon Web Services Inc. today announced the launch of the next phase of its Diagnostic Development Initiative to help fight the COVID-19 pandemic, which includes an expanded scope and $20 million of new funding.
During the first phase, AWS... |
| 09.04.2021 | IDbyDNA Shares Insights on Role of Metagenomics for Tracking COVID-19 on New Illumina Podcast | Medicine is on the cusp of the most dramatic change in infectious disease work since the discovery of antibiotics.
SAN FRANCISCO (PRWEB) April 09, 2021
Today, IDbyDNA, the company revolutionizing the use of metagenomics to improve health by... |
| 12.02.2021 | StartUPDATES: New developments from healthcare startups | Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing Boundaryless: #BuildfromAnywhere, slated for February 18th and featuring executives from major healthcare companies such as Abbott Laborator... |
| 08.02.2021 | IDbyDNA’s Leading Medical Experts to Speak on Respiratory Pathogen Detection via Precision Metagenomics at Illumina Webinar | IDbyDNA worked with Illumina to develop a new Respiratory ID/AMR Panel workflow and automated data analysis solution that simultaneously detects 300+ respiratory pathogens and nearly 1200 AMR markers in under 24 hours.
SAN FRANCISCO (PRWEB)... |
| 08.02.2021 | LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups | London, February 8, 2021: LifeArc announced today a £10 million cornerstone investment in the funding cycle of Illumina Accelerator Cambridge. This is part of over £20 million in initial UK capital commitments Illumina has secured from a se... |
| 02.02.2021 | Illumina and Sequoia Capital China partner to launch genomics incubator in China | Illumina and Sequoia Capital China partner to launch genomics incubator in China
02-02-2021
Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China, a leading investment fir... |
| 01.02.2021 | Illumina, Sequoia Capital China Launches Genomics Incubator in China | What You Should Know:
– Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics.
– Sequoia Capital China Intelligent Healthcare Genomics Incubato... |
| 16.12.2020 | Emedgene collaborates with Illumina to scale the interpretation of genomic data for rare diseases
USA - English
USA - English | |
| 03.12.2020 | Slone Partners Places John Leite as Chief Business Officer at InterVenn Biosciences | “John Leite is an experienced and highly accomplished business development and marketing specialist in the biotechnology and diagnostics sectors,” said Slone Partners President Tara Kochis-Stach.
SOUTH RIDING, Va. (PRWEB) December 03, 2020
... |
